Jose Maria Sanchez Tapias
Jose Maria Sanchez Tapias
Liver Unit. Hospital Clinic. Barcelona
Verified email at
Cited by
Cited by
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
X Forns, S Ampurdanes, JM Llovet, J Aponte, L Quintó, E Martınez-Bauer, ...
Hepatology 36 (4), 986-992, 2002
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
J Bruix, X Calvet, J Costa, M Ventura, M Bruguera, R Castillo, JM Barrera, ...
The Lancet 334 (8670), 1004-1006, 1989
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3
S Zeuzem, R Hultcrantz, M Bourliere, T Goeser, P Marcellin, ...
Journal of hepatology 40 (6), 993-999, 2004
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
JM Sánchez-Tapias, J Costa, A Mas, M Bruguera, J Rodés
Gastroenterology 123 (6), 1848-1856, 2002
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B
G Fattovich, G Giustina, SW Schalm, S Hadziyannis, J Sanchez-Tapias, ...
Hepatology 21 (1), 77-82, 1995
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients
M Laguno, J Murillas, JL Blanco, E Martínez, R Miquel, ...
Aids 18 (13), 27-36, 2004
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment
JM Sánchez–Tapias, M Diago, P Escartín, J Enríquez, M Romero–Gómez, ...
Gastroenterology 131 (2), 451-460, 2006
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study
G Realdi, G Fattovich, S Hadziyannis, SW Schalm, P Almasio, ...
Journal of hepatology 21 (4), 656-666, 1994
Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases
R Pérez-Alvarez, C Díaz-Lagares, F García-Hernández, L Lopez-Roses, ...
Medicine 90 (6), 359-371, 2011
Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation
A Sánchez‐Fueyo, A Rimola, L Grande, J Costa, A Mas, M Navasa, ...
Hepatology 31 (2), 496-501, 2000
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis
G Fattovich, G Giustina, J Sanchez-Tapias, C Quero, A Mas, PG Olivotto, ...
The American journal of gastroenterology 93 (6), 896-900, 1998
Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases
M Ramos-Casals, J Mañá, N Nardi, P Brito-Zerón, A Xaubet, ...
Medicine 84 (2), 69-80, 2005
Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft1
A Sánchez-Fueyo, JC Restrepo, L Quintó, M Bruguera, L Grande, ...
Transplantation 73 (1), 56-63, 2002
Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)
M Ramos-Casals, S Muñoz, F Medina, LJ Jara, J Rosas, J Calvo-Alen, ...
The Journal of rheumatology 36 (7), 1442-1448, 2009
Hospital admission is a relevant source of hepatitis C virus acquisition in Spain
E Martínez-Bauer, X Forns, M Armelles, R Planas, R Solà, M Vergara, ...
Journal of hepatology 48 (1), 20-27, 2008
Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients
M Laguno, C Cifuentes, J Murillas, S Veloso, M Larrousse, A Payeras, ...
Hepatology 49 (1), 22-31, 2009
Hepatitis C virus infection in patients with nonalcoholic chronic liver disease
JM Sánchez-Tapias, JM Barrera, J Costa, MÍG Ercilla, A Parés, ...
Annals of internal medicine 112 (12), 921-924, 1990
The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus
JC Sáiz, FX López-Labrador, S Ampurdanés, J Dopazo, X Forns, ...
Journal of Infectious Diseases 177 (4), 839-847, 1998
Prevalence and mother‐to‐infant transmission of hepatitis viruses B, C, and E in Southern Tanzania
C Menendez, JM Sanchez‐Tapias, E Kahigwa, H Mshinda, J Costa, ...
Journal of medical virology 58 (3), 215-220, 1999
Virologic, clinical, and immune response outcomes of patients with hepatitis C virus–associated cryoglobulinemia treated with direct-acting antivirals
M Bonacci, S Lens, MC Londoño, Z Mariño, MC Cid, M Ramos-Casals, ...
Clinical Gastroenterology and Hepatology 15 (4), 575-583. e1, 2017
The system can't perform the operation now. Try again later.
Articles 1–20